TAOPING INC (TAOP)

VGG8675V1278 - Common Stock

1.02  -0.04 (-3.77%)

Fundamental Rating

1

Overall TAOP gets a fundamental rating of 1 out of 10. We evaluated TAOP against 86 industry peers in the IT Services industry. Both the profitability and financial health of TAOP have multiple concerns. TAOP has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

TAOP had negative earnings in the past year.
In the past year TAOP has reported a negative cash flow from operations.
TAOP had negative earnings in 4 of the past 5 years.
TAOP had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

TAOP's Return On Assets of -24.28% is on the low side compared to the rest of the industry. TAOP is outperformed by 84.52% of its industry peers.
Looking at the Return On Equity, with a value of -72.81%, TAOP is doing worse than 71.43% of the companies in the same industry.
Industry RankSector Rank
ROA -24.28%
ROE -72.81%
ROIC N/A
ROA(3y)-34.25%
ROA(5y)-21.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TAOP's Gross Margin of 26.66% is on the low side compared to the rest of the industry. TAOP is outperformed by 67.86% of its industry peers.
In the last couple of years the Gross Margin of TAOP has declined.
The Profit Margin and Operating Margin are not available for TAOP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.63%
GM growth 5Y-8.19%

1

2. Health

2.1 Basic Checks

TAOP does not have a ROIC to compare to the WACC, probably because it is not profitable.
TAOP has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, TAOP has more shares outstanding
The debt/assets ratio for TAOP is higher compared to a year ago.

2.2 Solvency

TAOP has an Altman-Z score of -8.82. This is a bad value and indicates that TAOP is not financially healthy and even has some risk of bankruptcy.
TAOP has a worse Altman-Z score (-8.82) than 95.24% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that TAOP is somewhat dependend on debt financing.
TAOP has a Debt to Equity ratio (0.71) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z -8.82
ROIC/WACCN/A
WACC6.18%

2.3 Liquidity

TAOP has a Current Ratio of 1.07. This is a normal value and indicates that TAOP is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.07, TAOP is not doing good in the industry: 72.62% of the companies in the same industry are doing better.
TAOP has a Quick Ratio of 1.07. This is a bad value and indicates that TAOP is not financially healthy enough and could expect problems in meeting its short term obligations.
TAOP has a worse Quick ratio (0.76) than 84.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 0.76

2

3. Growth

3.1 Past

TAOP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -388.12%.
TAOP shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.05%.
Measured over the past years, TAOP shows a small growth in Revenue. The Revenue has been growing by 5.86% on average per year.
EPS 1Y (TTM)-388.12%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q13.26%
Revenue 1Y (TTM)37.05%
Revenue growth 3Y20.59%
Revenue growth 5Y5.86%
Revenue growth Q2Q92.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TAOP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TAOP indicates a rather cheap valuation: TAOP is cheaper than 96.43% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.21

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

TAOP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TAOPING INC

NASDAQ:TAOP (5/3/2024, 7:20:49 PM)

1.02

-0.04 (-3.77%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.61M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.28%
ROE -72.81%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 26.66%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.07
Quick Ratio 0.76
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-388.12%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)37.05%
Revenue growth 3Y20.59%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y